Evoli A - Search Results

1

Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment.

Fattorossi A, Battaglia A, Buzzonetti A, Ciaraffa F, Scambia G, Evoli A. Fattorossi A, et al. Among authors: evoli a. Immunology. 2005 Sep;116(1):134-41. doi: 10.1111/j.1365-2567.2005.02220.x. Immunology. 2005. PMID: 16108825 Free PMC article.

2

Successful treatment of myasthenia gravis with tacrolimus.

Evoli A, Di Schino C, Marsili F, Punzi C. Evoli A, et al. Muscle Nerve. 2002 Jan;25(1):111-4. doi: 10.1002/mus.10018. Muscle Nerve. 2002. PMID: 11754194

3

Anti-p110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement.

Scuderi F, Marino M, Colonna L, Mannella F, Evoli A, Provenzano C, Bartoccioni E. Scuderi F, et al. Among authors: evoli a. Lab Invest. 2002 Sep;82(9):1139-46. doi: 10.1097/01.lab.0000028144.48023.9b. Lab Invest. 2002. PMID: 12218074 Free article.

4

Paraneoplastic diseases associated with thymoma.

Evoli A, Minicuci GM, Vitaliani R, Battaglia A, Della Marca G, Lauriola L, Fattorossi A. Evoli A, et al. J Neurol. 2007 Jun;254(6):756-62. doi: 10.1007/s00415-006-0429-z. Epub 2007 Feb 26. J Neurol. 2007. PMID: 17325820

5

Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy.

Fattorossi A, Battaglia A, Buzzonetti A, Minicuci G, Riso R, Peri L, Scambia G, Evoli A. Fattorossi A, et al. Among authors: evoli a. J Clin Immunol. 2008 Mar;28(2):194-206. doi: 10.1007/s10875-007-9147-2. Epub 2007 Nov 14. J Clin Immunol. 2008. PMID: 18000743

6

Response to therapy in myasthenia gravis with anti-MuSK antibodies.

Evoli A, Bianchi MR, Riso R, Minicuci GM, Batocchi AP, Servidei S, Scuderi F, Bartoccioni E. Evoli A, et al. Ann N Y Acad Sci. 2008;1132:76-83. doi: 10.1196/annals.1405.012. Ann N Y Acad Sci. 2008. PMID: 18567856 Clinical Trial.

7

Comment on "Cutting edge: human CD4-CD8- thymocytes express FOXP3 in the absence of a TCR".

Battaglia A, Evoli A, Scambia G, Fattorossi A. Battaglia A, et al. Among authors: evoli a. J Immunol. 2008 Jul 15;181(2):857-8; author reply 858. doi: 10.4049/jimmunol.181.2.857. J Immunol. 2008. PMID: 18606635 No abstract available.

8

Determinants of cognitive impairment in elderly myasthenia gravis patients.

Marra C, Marsili F, Quaranta D, Evoli A. Marra C, et al. Among authors: evoli a. Muscle Nerve. 2009 Dec;40(6):952-9. doi: 10.1002/mus.21478. Muscle Nerve. 2009. PMID: 19768771

9

Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis.

Provenzano C, Marino M, Scuderi F, Evoli A, Bartoccioni E. Provenzano C, et al. Among authors: evoli a. J Neuroimmunol. 2010 Jan 25;218(1-2):102-6. doi: 10.1016/j.jneuroim.2009.11.004. Epub 2009 Nov 26. J Neuroimmunol. 2010. PMID: 19942297

10

Acquired myasthenia gravis in childhood.

Evoli A. Evoli A. Curr Opin Neurol. 2010 Oct;23(5):536-40. doi: 10.1097/WCO.0b013e32833c32af. Curr Opin Neurol. 2010. PMID: 20581680 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters